TNF and atherosclerosis: GV1001 remarkably blocked the in vitro EndMT caused by TNF-α and Pg LPS (Figure 9), indicating that the preventive effect of GV1001 on Pg-induced atherosclerosis might be partly due to GV1001’s anti-EndMT effect.